Samira Syed

578 total citations
37 papers, 390 citations indexed

About

Samira Syed is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Samira Syed has authored 37 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Samira Syed's work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (6 papers) and Erythrocyte Function and Pathophysiology (3 papers). Samira Syed is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (6 papers) and Erythrocyte Function and Pathophysiology (3 papers). Samira Syed collaborates with scholars based in United States, Sweden and Canada. Samira Syed's co-authors include Eric K. Rowinsky, Geoffrey R. Weiss, Garry Schwartz, Lisa A. Hammond, Anthony W. Tolcher, Elizabeth McCandlish, Brian Buckley, Michael Goedken, Ryan M. Pelis and Wen Xia and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Samira Syed

29 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samira Syed United States 11 151 122 94 55 47 37 390
Xiaoyi Zhang China 12 230 1.5× 161 1.3× 90 1.0× 66 1.2× 36 0.8× 38 487
David L. Doering United States 13 125 0.8× 137 1.1× 107 1.1× 54 1.0× 29 0.6× 21 503
L Anselmi Italy 7 188 1.2× 87 0.7× 103 1.1× 81 1.5× 33 0.7× 17 354
Daniela Martinetti Italy 10 101 0.7× 132 1.1× 69 0.7× 23 0.4× 35 0.7× 11 350
Alex Y. C. Chang United States 11 177 1.2× 133 1.1× 65 0.7× 93 1.7× 56 1.2× 27 437
Yvonne Sun United States 7 141 0.9× 309 2.5× 114 1.2× 106 1.9× 41 0.9× 7 631
Eufemia Savino Italy 13 161 1.1× 164 1.3× 122 1.3× 51 0.9× 27 0.6× 17 430
Masato Komoda Japan 11 186 1.2× 183 1.5× 54 0.6× 91 1.7× 26 0.6× 32 408
Ziyan Y. Pessetto United States 12 132 0.9× 284 2.3× 113 1.2× 67 1.2× 56 1.2× 22 521

Countries citing papers authored by Samira Syed

Since Specialization
Citations

This map shows the geographic impact of Samira Syed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samira Syed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samira Syed more than expected).

Fields of papers citing papers by Samira Syed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samira Syed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samira Syed. The network helps show where Samira Syed may publish in the future.

Co-authorship network of co-authors of Samira Syed

This figure shows the co-authorship network connecting the top 25 collaborators of Samira Syed. A scholar is included among the top collaborators of Samira Syed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samira Syed. Samira Syed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Fang, Yisheng, et al.. (2023). A rare case of advanced metaplastic breast carcinoma with response to treatment with Sacituzumab govitecan. SHILAP Revista de lepidopterología. 10. 100239–100239. 1 indexed citations
4.
5.
Unni, Nisha, et al.. (2022). Improving participation of under-represented minorities in breast cancer therapeutic trials in a safety-net system.. Journal of Clinical Oncology. 40(28_suppl). 90–90.
6.
Bergstrom, Colin P., Navid Sadeghi, Caitlin Mauer, et al.. (2020). Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations. Annals of Surgical Oncology. 28(6). 3383–3393. 15 indexed citations
7.
Wang, Sam C., et al.. (2019). Multidisciplinary Teams Improve Gastric Cancer Treatment Efficiency at a Large Safety Net Hospital. Annals of Surgical Oncology. 27(3). 645–650. 22 indexed citations
8.
Li, Jing, et al.. (2019). Impact of dual anti-HER2 therapy on pathologic complete response rate in breast cancer in a minority-enriched population.. Journal of Clinical Oncology. 37(15_suppl). e18111–e18111. 1 indexed citations
9.
Stern, Jennifer H., Yull Arriaga, Arjun Gupta, et al.. (2018). Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer. Pancreas. 48(1). e1–e3. 3 indexed citations
10.
Meyer, Jeffrey, Yull Arriaga, Samira Syed, et al.. (2017). A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma. American Journal of Clinical Oncology. 41(10). 972–976. 6 indexed citations
11.
Xia, Wen, Brian Buckley, Elizabeth McCandlish, et al.. (2014). Transgenic Expression of the Human MRP2 Transporter Reduces Cisplatin Accumulation and Nephrotoxicity in Mrp2-Null Mice. American Journal Of Pathology. 184(5). 1299–1308. 52 indexed citations
12.
Ghosn, Mohamad G., et al.. (2011). Time dependent changes in aortic tissue during cold storage in physiological solution. Biochimica et Biophysica Acta (BBA) - General Subjects. 1810(5). 555–560. 8 indexed citations
13.
Chu, Quincy, Bahram Forouzesh, Samira Syed, et al.. (2007). A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas. Investigational New Drugs. 25(4). 359–367. 46 indexed citations
14.
Osborn, Blaire L., Mili Gu, Krzysztof Grzegorzewski, et al.. (2004). Preliminary pharmacokinetic evaluation of Albuleukin; an interleukin-2 human serum albumin fusion protein, in solid tumor patients. Cancer Research. 64. 1099–1099. 9 indexed citations
15.
Beeram, Muralidhar, Geoffrey R. Weiss, Amita Patnaik, et al.. (2004). 369 A phase II, pharmacokinetic (PK) and biological correlative study of OSI-774 (Tarceva) in patients with advanced renal cell carcinoma, with FDG-PET imaging: evidence of durable stable disease and antitumor activity. European Journal of Cancer Supplements. 2(8). 111–111. 6 indexed citations
16.
Syed, Samira, Tony Y. Eng, Charles R. Thomas, Ian M. Thompson, & Geoffrey R. Weiss. (2003). Current issues in the management of advanced squamous cell carcinoma of the penis. Urologic Oncology Seminars and Original Investigations. 21(6). 431–438. 10 indexed citations
17.
Syed, Samira, Daniel P. Petrylak, & Ian M. Thompson. (2003). Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches. Urologic Oncology Seminars and Original Investigations. 21(3). 235–243. 9 indexed citations
18.
Syed, Samira & Anthony W. Tolcher. (2003). Novel Therapies for Renal Cell Carcinoma. Cancer treatment and research. 116. 227–238. 1 indexed citations
19.
Syed, Samira & Geoffrey R. Weiss. (2002). Management of locally advanced bladder cancer: early vs deferred chemotherapy. World Journal of Urology. 20(3). 175–182. 2 indexed citations
20.
Syed, Samira, David Sears, Jochewed Werch, Mark M. Udden, & John D. Milam. (1996). Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease. The American Journal of the Medical Sciences. 312(4). 175–181. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyi Zhang Breakdown of academic impact, for papers by David L. Doering Breakdown of academic impact, for papers by L Anselmi Breakdown of academic impact, for papers by Daniela Martinetti Breakdown of academic impact, for papers by Alex Y. C. Chang Breakdown of academic impact, for papers by Yvonne Sun Breakdown of academic impact, for papers by Eufemia Savino Breakdown of academic impact, for papers by Masato Komoda Breakdown of academic impact, for papers by Ziyan Y. Pessetto
Rankless by CCL
2026